CIK 0001750284 · Non-accelerated filer<br>Smaller reporting company
Olema Oncology, Inc.
Sign in to watch- Ticker
- OLMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 300409740
- Phone
- (415) 651-3316
- Business address
- 365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Olema Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-01 | O'Byrne Jason CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +650,000 | 650,000 | ||
| 2026-07-24 | Harmon Cyrus Director | Sale | −12,500 | $11.71 | $146K | 702,770 |
| 2026-07-23 | Harmon Cyrus Director | Sale | −12,500 | $11.58 | $145K | 715,270 |
| 2026-06-18 | Raman Prakash Director | Grant or award · Stock Option (right to buy) | +29,500 | 29,500 | ||
| 2026-06-18 | Harmon Cyrus Director | Grant or award · Stock Option (Right to Buy) | +29,500 | 29,500 | ||
| 2026-06-18 | Hrustanovic Gorjan Director | Grant or award · Stock Option (right to buy) | +29,500 | 29,500 | ||
| 2026-06-18 | Larson Yi Director | Grant or award · Stock Option (right to buy) | +29,500 | 29,500 | ||
| 2026-06-18 | Graham G. Walmsley Director | Grant or award · Stock Option (right to buy) | +29,500 | 29,500 | ||
| 2026-06-18 | Horning Sandra Director | Grant or award · Stock Option (right to buy) | +29,500 | 29,500 | ||
| 2026-06-18 | Garland J. Scott Director | Grant or award · Stock Option (right to buy) | +29,500 | 29,500 | ||
| 2026-06-18 | CLARK IAN T Director | Grant or award · Stock Option (right to buy) | +29,500 | 29,500 | ||
| 2026-06-18 | BUTITTA CYNTHIA M Director | Grant or award · Stock Option (right to buy) | +29,500 | 29,500 | ||
| 2026-06-18 | RAPPAPORT ANDREW Director | Grant or award · Stock Option (right to buy) | +29,500 | 29,500 | ||
| 2026-06-18 | BVF PARTNERS L P/IL Director | Grant or award · Stock Option (Right to buy) | +29,500 | 29,500 | ||
| 2026-04-28 | Raman Prakash Director | Grant or award · Stock Option (Right to Buy) | +2,911 | 2,911 | ||
| 2026-04-28 | Raman Prakash Director | Grant or award · Stock Option (Right to Buy) | +24,150 | 24,150 | ||
| 2026-03-04 | Mitchell Shawnte CHIEF LEGAL OFFICER | Option exercise | +25,000 | $4.37 | $109K | 25,000 |
| 2026-03-04 | Mitchell Shawnte CHIEF LEGAL OFFICER | Sale | −24,767 | $24.25 | $601K | 233 |
| 2026-03-04 | Mitchell Shawnte CHIEF LEGAL OFFICER | Sale | −233 | $24.69 | $6K | 0 |
| 2026-03-04 | Mitchell Shawnte CHIEF LEGAL OFFICER | Option exercise · Stock Option (Right to Buy) | −25,000 | 410,000 |
Page 1 of 11 · 207 trades